Cargando…

Feasibility of gray-blood late gadolinium enhancement evaluation in young patients with congenital and acquired heart disease

BACKGROUND: Late gadolinium enhancement (LGE) sequences have become common in pediatric cardiovascular magnetic resonance (CMR) to assess for myocardial fibrosis. Bright-blood late gadolinium enhancement (BB-LGE) by conventional phase-sensitive inversion recovery (PSIR) is commonly utilized, but sim...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez de Alba, Cesar, Moghari, Mehdi H., Browne, Lorna P., Friesen, Richard M., Fonseca, Brian, Malone, LaDonna J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616296/
https://www.ncbi.nlm.nih.gov/pubmed/37915741
http://dx.doi.org/10.3389/fcvm.2023.1269412
_version_ 1785129363581173760
author Gonzalez de Alba, Cesar
Moghari, Mehdi H.
Browne, Lorna P.
Friesen, Richard M.
Fonseca, Brian
Malone, LaDonna J.
author_facet Gonzalez de Alba, Cesar
Moghari, Mehdi H.
Browne, Lorna P.
Friesen, Richard M.
Fonseca, Brian
Malone, LaDonna J.
author_sort Gonzalez de Alba, Cesar
collection PubMed
description BACKGROUND: Late gadolinium enhancement (LGE) sequences have become common in pediatric cardiovascular magnetic resonance (CMR) to assess for myocardial fibrosis. Bright-blood late gadolinium enhancement (BB-LGE) by conventional phase-sensitive inversion recovery (PSIR) is commonly utilized, but similar inversion time (TI) value of fibrosis and left ventricular (LV) blood pool can make subendocardial areas difficult to assess. A gray-blood LGE (GB-LGE) technique has been described, targeting nulling of the LV blood pool and demonstrating improvement in ischemic scar detection over BB-LGE in adult patients. We sought to evaluate the feasibility of the GB-LGE technique in a young population with congenital and acquired heart disease and compare its ability to detect subendocardial scar to conventional BB-LGE. METHODS: Seventy-six consecutive patients referred for clinical CMR underwent both BB-LGE and GB-LGE on 1.5 T and 3 T scanners. Conventional PSIR sequences were obtained with TI to null the myocardium (BB-LGE) in short-axis and horizontal long-axis stacks. Same PSIR stacks were immediately repeated with TI to null the blood pool (GB-LGE). Both sequences were reviewed separately a week apart by two readers, blinded to the initial clinical interpretation. Studies were analyzed for overall image quality, confidence in scar detection, confidence in detection of LGE, LGE class, inter- and intra-observer agreement for the presence of scar, and intraclass correlation coefficient (ICC) for total scar burden. RESULTS: Overall confidence in myocardial scar detection by BB-LGE or GB-LGE as well as grading of image quality were not statistically different [(p = 1 and p = 1) and (p = 0.53, p = 0.18), respectively]. There was very good inter-observer agreement for the presence of scar on BB-LGE (K = 0.88, 95% CI 0.77–0.99) and GB-LGE (K = 0.84, 95% CI 0.7–0.96), as well as excellent intra-observer agreement for both readers (K = 0.93, 95% CI 0.87–0.99; and K = 0.81, 95% CI 0.69–0.95). Interclass correlation coefficient for total scar burden was excellent for BB-LGE (ICC = 0.98, 95% CI 0.96–0.99) and GB-LGE (ICC = 0.94, 95% CI 0.91–0.97). CONCLUSIONS: The GB-LGE technique is feasible in the pediatric population with congenital and acquired heart disease. It can detect subendocardial/ischemic scar similar to conventional bright-blood PSIR sequences in the pediatric population.
format Online
Article
Text
id pubmed-10616296
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106162962023-11-01 Feasibility of gray-blood late gadolinium enhancement evaluation in young patients with congenital and acquired heart disease Gonzalez de Alba, Cesar Moghari, Mehdi H. Browne, Lorna P. Friesen, Richard M. Fonseca, Brian Malone, LaDonna J. Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Late gadolinium enhancement (LGE) sequences have become common in pediatric cardiovascular magnetic resonance (CMR) to assess for myocardial fibrosis. Bright-blood late gadolinium enhancement (BB-LGE) by conventional phase-sensitive inversion recovery (PSIR) is commonly utilized, but similar inversion time (TI) value of fibrosis and left ventricular (LV) blood pool can make subendocardial areas difficult to assess. A gray-blood LGE (GB-LGE) technique has been described, targeting nulling of the LV blood pool and demonstrating improvement in ischemic scar detection over BB-LGE in adult patients. We sought to evaluate the feasibility of the GB-LGE technique in a young population with congenital and acquired heart disease and compare its ability to detect subendocardial scar to conventional BB-LGE. METHODS: Seventy-six consecutive patients referred for clinical CMR underwent both BB-LGE and GB-LGE on 1.5 T and 3 T scanners. Conventional PSIR sequences were obtained with TI to null the myocardium (BB-LGE) in short-axis and horizontal long-axis stacks. Same PSIR stacks were immediately repeated with TI to null the blood pool (GB-LGE). Both sequences were reviewed separately a week apart by two readers, blinded to the initial clinical interpretation. Studies were analyzed for overall image quality, confidence in scar detection, confidence in detection of LGE, LGE class, inter- and intra-observer agreement for the presence of scar, and intraclass correlation coefficient (ICC) for total scar burden. RESULTS: Overall confidence in myocardial scar detection by BB-LGE or GB-LGE as well as grading of image quality were not statistically different [(p = 1 and p = 1) and (p = 0.53, p = 0.18), respectively]. There was very good inter-observer agreement for the presence of scar on BB-LGE (K = 0.88, 95% CI 0.77–0.99) and GB-LGE (K = 0.84, 95% CI 0.7–0.96), as well as excellent intra-observer agreement for both readers (K = 0.93, 95% CI 0.87–0.99; and K = 0.81, 95% CI 0.69–0.95). Interclass correlation coefficient for total scar burden was excellent for BB-LGE (ICC = 0.98, 95% CI 0.96–0.99) and GB-LGE (ICC = 0.94, 95% CI 0.91–0.97). CONCLUSIONS: The GB-LGE technique is feasible in the pediatric population with congenital and acquired heart disease. It can detect subendocardial/ischemic scar similar to conventional bright-blood PSIR sequences in the pediatric population. Frontiers Media S.A. 2023-10-17 /pmc/articles/PMC10616296/ /pubmed/37915741 http://dx.doi.org/10.3389/fcvm.2023.1269412 Text en © 2023 Gonzalez de Alba, Moghari, Browne, Friesen, Fonseca and Malone. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Gonzalez de Alba, Cesar
Moghari, Mehdi H.
Browne, Lorna P.
Friesen, Richard M.
Fonseca, Brian
Malone, LaDonna J.
Feasibility of gray-blood late gadolinium enhancement evaluation in young patients with congenital and acquired heart disease
title Feasibility of gray-blood late gadolinium enhancement evaluation in young patients with congenital and acquired heart disease
title_full Feasibility of gray-blood late gadolinium enhancement evaluation in young patients with congenital and acquired heart disease
title_fullStr Feasibility of gray-blood late gadolinium enhancement evaluation in young patients with congenital and acquired heart disease
title_full_unstemmed Feasibility of gray-blood late gadolinium enhancement evaluation in young patients with congenital and acquired heart disease
title_short Feasibility of gray-blood late gadolinium enhancement evaluation in young patients with congenital and acquired heart disease
title_sort feasibility of gray-blood late gadolinium enhancement evaluation in young patients with congenital and acquired heart disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616296/
https://www.ncbi.nlm.nih.gov/pubmed/37915741
http://dx.doi.org/10.3389/fcvm.2023.1269412
work_keys_str_mv AT gonzalezdealbacesar feasibilityofgraybloodlategadoliniumenhancementevaluationinyoungpatientswithcongenitalandacquiredheartdisease
AT mogharimehdih feasibilityofgraybloodlategadoliniumenhancementevaluationinyoungpatientswithcongenitalandacquiredheartdisease
AT brownelornap feasibilityofgraybloodlategadoliniumenhancementevaluationinyoungpatientswithcongenitalandacquiredheartdisease
AT friesenrichardm feasibilityofgraybloodlategadoliniumenhancementevaluationinyoungpatientswithcongenitalandacquiredheartdisease
AT fonsecabrian feasibilityofgraybloodlategadoliniumenhancementevaluationinyoungpatientswithcongenitalandacquiredheartdisease
AT maloneladonnaj feasibilityofgraybloodlategadoliniumenhancementevaluationinyoungpatientswithcongenitalandacquiredheartdisease